Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe

Journal of Hepatology

Volumn 56, Issue 3, 2012, Pages 564-570

  Myers, Robert P ^a   Pomier Layrargues, Gilles ^b   Kirsch, Richard ^c   Pollett, Aaron ^c   Beaton, Melanie ^d   Levstik, Mark ^d   Duarte Rojo, Andres ^e   Wong, David ^e   Crotty, Pam ^a   Elkashab, Magdy ^f  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e TORONTO WESTERN HOSPITAL   (Canada)

^f Toronto Liver Centre   (Canada)

Author keywords

Biomarker; Biopsy; Fibrosis; Stiffness

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STAGING; VIRUS HEPATITIS;

ADULT; BIOPSY; CHRONIC DISEASE; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84857369747     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.10.007     Document Type: Article

References (36)

1. D.C. Rockey, S.H. Caldwell, and Z.D. Goodman Liver biopsy Hepatology 49 2009 1017 1044
2. R.P. Myers, A. Fong, and A.A. Shaheen Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies Liver Int 28 2008 705 712
3. P. Bedossa, D. Dargere, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
4. A. Regev, M. Berho, and L.J. Jeffers Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2002 2614 2618
5. I.N. Guha, R.P. Myers, and K. Patel Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve? Hepatology 54 2011 1454 1462
6. R.P. Myers Noninvasive diagnosis of nonalcoholic fatty liver disease Ann Hepatol 8 2009 S25 33
7. L. Castera, X. Forns, and A. Alberti Non-invasive evaluation of liver fibrosis using transient elastography J Hepatol 48 2008 835 847
8. R.P. Myers, M. Elkashab, and M. Ma Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study Can J Gastroenterol 24 2010 661 670
9. M. Friedrich-Rust, M.F. Ong, and S. Martens Performance of transient elastography for the staging of liver fibrosis: a meta-analysis Gastroenterology 134 2008 960 974
10. A.A. Shaheen, A.F. Wan, and R.P. Myers FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy Am J Gastroenterol 102 2007 2589 2600
11. U. Arena, F. Vizzutti, and J.G. Abraldes Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C Gut 57 2008 1288 1293
12. L. Castera, J. Foucher, and P.H. Bernard Pitfalls of liver stiffness measurement: a 5-year prospective study of 13, 369 examinations Hepatology 51 2010 828 835
13. J. Foucher, L. Castera, and P.H. Bernard Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations Eur J Gastroenterol Hepatol 18 2006 411 412
14. D. Lucidarme, J. Foucher, and B. Le Bail Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C Hepatology 49 2009 1083 1089
15. R.P. Myers, P. Crotty, and G. Pomier-Layrargues Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy Liver Int 30 2010 1471 1480
16. D. Roulot, S. Czernichow, and H. Le Clesiau Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome J Hepatol 48 2008 606 613
17. G.L. Wong, V.W. Wong, and A.M. Chim Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population J Gastroenterol Hepatol 26 2011 300 305
18. V. de Ledinghen, J. Vergniol, and J. Foucher Feasibility of liver transient elastography with FibroScan using a new probe for obese patients Liver Int 30 2010 1043 1048
19. M. Friedrich-Rust, H. Hadji-Hosseini, and S. Kriener Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis Eur Radiol 20 2010 2390 2396
20. Myers RP, Pomier-Layrargues G, Kirsch R, et al. Feasibility and performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2011. doi:10.1002/hep.24624.
21. M. Fraquelli, C. Rigamonti, and G. Casazza Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C J Hepatol 54 2011 621 628
22. S.U. Kim, Y.S. Seo, and J.Y. Cheong Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B Aliment Pharmacol Therap 32 2010 498 505
23. V.W. Wong, J. Vergniol, and G.L. Wong Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease Hepatology 51 2009 454 462
24. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
25. A.A. Shaheen, and R.P. Myers Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review Hepatology 46 2007 912 921
26. D.E. Kleiner, E.M. Brunt, and M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
27. The French METAVIR Cooperative Study Group Intraobserver, interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 20 1994 15 20
28. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
29. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
30. T. Poynard, M. Munteanu, and F. Imbert-Bismut Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C Clin Chem 50 2004 1344 1355
31. M. Bourliere, G. Penaranda, and C. Renou Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies J Viral Hepat 13 2006 659 670
32. L. Castera, J. Vergniol, and J. Foucher Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
33. P. Marcellin, M. Ziol, and P. Bedossa Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B Liver Int 29 2009 242 247
34. S.H. Mehta, B. Lau, and N.H. Afdhal Exceeding the limits of liver histology markers J Hepatol 50 2009 36 41
35. T. Poynard, P. Halfon, and L. Castera Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation Aliment Pharmacol Therap 25 2007 733 739
36. T. Poynard, J. McHutchison, and M. Manns Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin Hepatology 38 2003 481 492